"EURETINA-2013" XIII Congress of the European Society of vitreoretinal specialists

Section:Mass media about us
2.jpg26-29 September 2013 Hamburg (Germany) hosted the XIII Congress of the European Society of vitreoretinal specialists («EURETINA - 2013"). The venue of the event was The Congress Center of Hamburg - Germany's largest exhibition center. This year congress acknowledged to be the greatest in the history of the Society. This is due to large number of participants, an extensive exhibition, multitasking of sessions. Traditionally, the congress was held in English language.

The congress was attended by more than 4500 experts and researchers in the field of pathology of retina and vitreous from 98 countries . The scientific program of the congress included 10 main sessions , 30 courses , 20 sessions of oral presentations and 16 satellite symposia . Meetings were held simultaneously in nine halls. The main directions of the Congress: age-related macular degeneration, surgery of anterior and posterior eye segments, intraocular tumors, new technologies in therapy of retinal pathology , uveitis , diabetic eye disease , vitreoretinal surgery .


At the opening ceremony prof. Gisbert Richard, the president of EURETINA, noted that the annual congress of vitreoretinal specialists provides the main impetus for research and development of vitreoretinal surgery: "Our task is to preserve what we have achieved, to promote and develop innovations without losing the individuality of Ophthalmology".

Within the framework of opening ceremony of the Congress the President of EURETINA prof. G.Richard awarded honorary diplomas of the European Society of vitreoretinal specialists to Professor Mark Blumenkranz (USA), Prof. Leonidas Zografos (Greece) and Prof. M.M. Bikbov (Russia).

4.jpgProf. Leonidas Zografos presented the report on «Radiotherapy on Ocular Oncology», in which he expounded possibilities in the treatment of neoplasms of the eye. Prof. Mark Blumenkranz was awarded as the best speaker. In his work «Evolving concepts in innovation and academic technology transfer in the vitreoretinal world: Lessons learned in Silicon Valley» prof. M. Blumenkranz presented the modern trends in the use of nanotechnologies in ophthalmology. The Director of Ufa Eye Research Institute prof. M.M. Bikbov was awarded a diploma for his contribution to ophthalmology, for the implementation of scientific and clinical collaboration between East and West. To the diploma was attached a check for a lump sum from the Vereinigung der Freunde der Universität Tübingen EV

To celebrate the 60th anniversary since the invention of photocoagulation Gerd Meyer-Schwickerath at an eye clinic University Eye Clinic Hamburg-Eppendorf was held a symposium  «Laser in Ophthalmology».

The main sessions were devoted to the problems of diagnosis and treatment of various types of ophthalmopathology: intraocular tumors, neovascularization in age-related macular degeneration, inflammatory eye diseases, wet form of macular degeneration, retinal vein occlusion disease, proliferative vitreoretinopathy and rhegmatogenous retinal detachment, diabetic retinopathy. The issue of mapping of pathological changes in the fundus and innovative technologies in vitreoretinal surgery were also considered.


At the session on intraocular neoplasm most of the reports were devoted to the methods of diagnosis and treatment of melanoma. Dr. M. Zeschnigk (Germany) presented a report on the dependence of the pathological process of intraocular tumors on the genetic status, inherited in an autosomal dominant manner. Prof. N. Bechrakis (Austria) proposed new methods of surgical treatment to reduce the recurrence of the pathological process.

Session on neovascularization in age-related macular degeneration of the retina, included a large number of reports on antivazoproliferativnoy therapy. Dr. N. Ferrara and R. Spaide (USA) presented the independent work on the differential approach to the use of  antivazoproliferative drugs. The urgency of this problem stems from the fact that angiogenesis inhibitors are currently used regardless of the degree of fibrosis of foveolar zone, what reduces the effectiveness of the therapy. Similar questions are studied in the framework of international research, in particular, IVAN trial, the results of which  presented prof. U. Chakravarthy (UK). Given the severity of the central area of retinal in macular degeneration, many researchers do not stop searching for new technologies. So, Dr. L. Da Cruz (UK) presented his vision of use of technology in the treatment of transplant pathology of the central retina.

To date, the emergence of new diagnostic equipment in ophthalmology enables mapping of different layers of the retina and the vascular bed. At the core of the meeting was organized session on graphical visualization of pathological structures of fundus, which included presentations on the use of optical coherence tomography (Dr. C. Boon, Netherlands, Dr. S. Schmitz-Valckenberg, Germany) and fluorescein angiography (Dr. S. Wolf, Switzerland, Dr. G. Staurenghi, Italy).

R.R. Faizrakhmanov


Back to the list